Imported Cutaneous Diphtheria, United Kingdom by de Benoist, Anne-Claire et al.
Imported
Cutaneous
Diphtheria, United
Kingdom 
Anne-Claire de Benoist,* Joanne Margaret
White,* Androulla Efstratiou,† Carole Kelly,†
Ginder Mann,† Bernadette Nazareth,‡ 
Charles James Irish,§ Deepti Kumar,¶ 
and Natasha Sarah Crowcroft*
Cutaneous diphtheria is endemic in tropical countries
but unusual in the United Kingdom. Four cases occurred in
the United Kingdom within 2 months in 2002. Because
cutaneous diphtheria causes outbreaks of both cutaneous
and pharyngeal forms, early diagnosis is essential for
implementing control measures; high diphtheria vaccina-
tion coverage must also be maintained. 
W
e report four cases of cutaneous diphtheria that
occurred in the United Kingdom during a 2-month
period in 2002 and review past cases.
The Study
Patient 1
In September 2002, a 6-year-old girl appeared for treat-
ment with an infected mosquito bite on the ankle and chest
lesions. The lesions developed while she was traveling
with her mother and four siblings in Bangladesh. Her 12-
year-old sister also had infected mosquito bites on her feet.
Swab specimens, taken from the chest lesions and feet,
were microbiologically cultured. Staphylococcus aureus,
Streptococcus pyogenes, and toxigenic Corynebacterium
diphtheriae var mitis were isolated from the specimens.
The 6-year-old had received flucloxacillin for 5 days
before the antimicrobial agent was changed to erythromy-
cin. She had received three primary doses of diphtheria
vaccine at birth, 5 months, and 9 months, and a booster
vaccination in 2001. The 12- year-old was initially treated
as a contact with 7 days of erythromycin; this treatment
was extended to 14 days when the laboratory confirmed C.
diphtheriae infection. She had received three primary
diphtheria vaccine doses in 1994, but no booster. The chil-
dren’s mother had received one dose of tetanus-diphtheria
(Td) toxoid in July 2002, and their father, a household con-
tact, had no immunization record.The remaining siblings
had received at least three primary doses of diphtheria vac-
cine, and one had received a booster. Nose and throat
swabs from all six members of the family, including the
two patients, were negative for C. diphtheriae. The four
contacts were given antimicrobial prophylaxis and com-
pleted immunization as appropriate. The two girls were
kept home from school until their antibiotic regimen was
completed and clearance swabs of the lesions taken 24
hours apart were confirmed as negative. 
Ribotyping, a universal molecular typing method for
bacteria based upon rRNAgene restriction pattern determi-
nation, was performed on the isolates from the two siblings.
The ribotype patterns produced were indistinguishable
from each other. The girls’ schools were asked for lists of
all children who had been in contact with the two patients
to establish their diphtheria immunization status as shown
on the Child Health System (a population-based register of
all children living in each locality, which includes informa-
tion on vaccination status and other health indices). In addi-
tion, an information letter was sent to all parents.
Patient 2
In September 2002, an 8-year-old Somalian girl, who
had been in the United Kingdom for 4 months, was hospi-
talized with lesions on her legs and scalp, a sore throat, but
no fever. She had no history of diphtheria immunization.
The swabs from the throat and lesions yielded toxigenic C.
diphtheriae var  mitis. The organism isolated from the
throat was only identified because the microbiology
department screened all throat swabs routinely for
corynebacteria. S. aureus was also isolated from the skin
lesions. She was treated with flucloxacillin and penicillin.
The skin lesions had been swabbed before September but
had not been examined for C. diphtheriae. The isolates
from the throat swab and the lesion were genotyped, and
the ribotype patterns that resulted were identical. Two
adults and five unvaccinated siblings were identified as
contacts. After screening, all were negative for C. diphthe-
riae and were offered vaccination.
Patient 3
At the end of October 2002, an 81-year-old man
returned to England from Pakistan with an infected mos-
quito bite. Toxigenic C. diphtheriae var mitis was isolated
from the lesion. The patient received diphtheria antitoxin
and was treated with erythromycin and clarithromycin for
14 days. He had no history of diphtheria immunization. He
had traveled alone to Pakistan. Twelve of his close contacts
in the United Kingdom required microbiologic screening,
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*Immunisation Division, Health Protection Agency, London, United
Kingdom; †Respiratory and Systemic Infection Laboratory,
Streptococcus and Diptheria Reference Unit, Health Protection
Agency, London, United Kingdom; ‡Cambridgeshire and
Peterborough Public Health Protection Unit, Huntington, United
Kingdom; §Avon Health Protection Unit, Bristol, United Kingdom;
and ¶Ealing Primary Care Trust,  London, United Kingdom although C. diphtheriae was not isolated from any. The
contacts received erythromycin prophylaxis and were
offered vaccine, except for two children who had already
been vaccinated. Information also was sent to the patient’s
contacts in Pakistan.
Conclusions
In the United Kingdom, 17 patients with cases of cuta-
neous diphtheria due to toxigenic C. diphtheriae were
reported from 1995 to 2002. All cases were travel-related
(Table). Of 15 patients with a vaccination history, 6 were
fully immunized (four primary doses by 5 years of age), 2
had received three doses of vaccine, and 7 had not been
vaccinated. 
In 1985, one patient with a secondary laryngeal case
and a total of 16 carriers, including 8 who were secondary
contacts of carriers, were associated with one cutaneous
case. Dissemination to children and adults in several class-
es, schools, and households occurred within just 20 days
(1). A patient in 1998 generated two asymptomatic carri-
ers. The two sisters in 2002 acquired their lesions at
approximately the same time, and thus we cannot deter-
mine whether they were infected by the same source or
whether one infected the other. 
High vaccination coverage is critical. The greater
spread of infection after the 1985 case might be related to
lower vaccination coverage at that time. In 1985, primary
immunization for diphtheria was 85% compared to the cur-
rent rate of 94%. 
Cutaneous diphtheria, still endemic in tropical coun-
tries, is the most common nonrespiratory clinical manifes-
tation of infection due to toxigenic isolates of C.
diphtheriae (2). The disease is characterized by shallow
skin ulcers, which can occur anywhere on the body and are
usually chronic. They are often associated with infected
insect bites, frequently coinfected with pathogens such as
S. aureus and S. pyogenes. Systemic toxic manifestations
are uncommon among immunized persons. Skin lesions
absorb toxin slowly and can induce high levels of antibod-
ies that produce natural immunization. These lesions are
an important reservoir of infection and can cause respira-
tory and cutaneous infections in contacts as well as out-
breaks (3). In several outbreaks, secondary transmission
has been higher in contacts of patients with cutaneous
infection than in those with respiratory tract infection.
Cutaneous diphtheria may also cause greater environmen-
tal contamination, through dust and fomites (4). 
Cutaneous diphtheria is still being reported in the
United Kingdom, even in vaccinated patients and despite
high diphtheria vaccination coverage. All cases so far have
been acquired in countries where diphtheria is endemic.
With increasing travel to and from these countries, more
cases may occur. The potential for secondary transmission
leads to a large number of contacts requiring follow-up,
especially children at school. Moreover, cutaneous diph-
theria is likely to be diagnosed less quickly than respirato-
ry infection because the clinical appearance is nonspecific,
and other pathogens often coinfect the lesions. Thus, we
need to increase the awareness of clinicians and microbiol-
ogists of the importance of obtaining swab specimens from
any chronic nonhealing skin lesions in patients who have
traveled to a disease-endemic area. Wound swab samples
from these patients should be examined for C. diphtheriae.
Early diagnoses and reporting are crucial to trigger effec-
tive public health control measures (5).
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Table. Distribution by year of cutaneous diphtheria cases caused by toxigenic Corynebacterium diphtheriae strains reported in the 
United Kingdom, 1985–2002 
Y  Month  Sex  Age  Biotype  Specimen  Immunization status  Associated country 
1985  Sept  M  5  gravis  Scalp  4 primary doses  Bangladesh 
1990  Oct  F  19  mitis  Skin  Unvaccinated  Pakistan 
1992  May  F  25  mitis  Foot. Insect bites  Unknown  Ghana 
1992  July  F  8  mo  mitis  Skin  Unvaccinated  Bangladesh 
1993  June  F  43  mitis  Mosquito bites  Unvaccinated  Gambia 
1993  NA
a  M  20  gravis  Skin (RTA)
b  Unvaccinated  Pakistan 
1994  NA
a  F  64  mitis  Foot (leprosy)  Unvaccinated  Bangladesh 
1994  Sept  F  32  mitis  Foot, throat (membrane)  4 primary doses  India 
1995  March  M  27  mitis  Skin  4 primary doses  Thailand 
1996  Nov  M  27  intermedius  Insect bites  4 primary doses  Nepal and Thailand 
1997  Dec/Jan  M  39  mitis  Foot  4 primary doses + booster  Indonesia 
1998  July  M  19  mitis  Leg wound  4 primary doses + booster  Tanzania 
2000  Nov  F  44  mitis  Toe (diabetes)  Unknown  Gambia 
2002  Sept  F  6  mitis  Chest  3 primary doses  Bangladesh 
2002  Sept  F  12  mitis  Feet  3 primary doses  Bangladesh 
2002  Oct.  M  81  mitis  Skin  Unvaccinated  Pakistan 
2002  Sept.  F  8  mitis  Leg, scalp, throat  Unvaccinated  Somalia 
aNot available. 
bRoad traffic accident. Ms. de Benoist was funded through the European
Programme for Intervention Epidemiology by Directorate-
General SANCO of the European Commission.
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